Pages that link to "Q30542085"
Jump to navigation
Jump to search
The following pages link to Human cervicovaginal mucus contains an activity that hinders HIV-1 movement. (Q30542085):
Displaying 50 items.
- Sex hormones selectively impact the endocervical mucosal microenvironment: implications for HIV transmission (Q21090622) (← links)
- Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health (Q21129223) (← links)
- Progress and Perspectives on HIV-1 microbicide development (Q26739967) (← links)
- Preventing HIV infection: pre-exposure and postexposure prophylaxis (Q26828445) (← links)
- Antibody responses to envelope glycoproteins in HIV-1 infection (Q26991572) (← links)
- Increases in Endogenous or Exogenous Progestins Promote Virus-Target Cell Interactions within the Non-human Primate Female Reproductive Tract (Q27311833) (← links)
- Tracking the luminal exposure and lymphatic drainage pathways of intravaginal and intrarectal inocula used in nonhuman primate models of HIV transmission (Q27313356) (← links)
- HSV-2-driven increase in the expression of α4β7 correlates with increased susceptibility to vaginal SHIV(SF162P3) infection (Q27322178) (← links)
- Modeling neutralization kinetics of HIV by broadly neutralizing monoclonal antibodies in genital secretions coating the cervicovaginal mucosa (Q27322437) (← links)
- Antimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosis (Q28081831) (← links)
- IgG in cervicovaginal mucus traps HSV and prevents vaginal herpes infections (Q30585914) (← links)
- HIV-1 vaccines: challenges and new perspectives (Q33577972) (← links)
- Transient antibody-mucin interactions produce a dynamic molecular shield against viral invasion (Q33595754) (← links)
- Induction of Potent and Long-Lived Antibody and Cellular Immune Responses in the Genitorectal Mucosa Could be the Critical Determinant of HIV Vaccine Efficacy (Q33611645) (← links)
- HIV-1 specific IgA detected in vaginal secretions of HIV uninfected women participating in a microbicide trial in Southern Africa are primarily directed toward gp120 and gp140 specificities (Q33939974) (← links)
- Nonneutralizing functional antibodies: a new "old" paradigm for HIV vaccines (Q34057711) (← links)
- Vaccine-induced HIV-1 envelope gp120 constant region 1-specific antibodies expose a CD4-inducible epitope and block the interaction of HIV-1 gp140 with galactosylceramide (Q34059103) (← links)
- The effects of reproductive hormones on the physical properties of cervicovaginal fluid. (Q34111702) (← links)
- Exogenous and endogenous hyaluronic acid reduces HIV infection of CD4(+) T cells (Q34385257) (← links)
- Vaginal pH and microbicidal lactic acid when lactobacilli dominate the microbiota (Q35040378) (← links)
- Innate immunity in the vagina (Part II): Anti-HIV activity and antiviral content of human vaginal secretions (Q35078336) (← links)
- Evolutionary distance of amino acid sequence orthologs across macaque subspecies: identifying candidate genes for SIV resistance in Chinese rhesus macaques (Q35462419) (← links)
- Characterization of the Influence of Semen-Derived Enhancer of Virus Infection on the Interaction of HIV-1 with Female Reproductive Tract Tissues (Q35641451) (← links)
- Modeling of Virion Collisions in Cervicovaginal Mucus Reveals Limits on Agglutination as the Protective Mechanism of Secretory Immunoglobulin A. (Q35679948) (← links)
- Randomized Cross-Sectional Study to Compare HIV-1 Specific Antibody and Cytokine Concentrations in Female Genital Secretions Obtained by Menstrual Cup and Cervicovaginal Lavage (Q35683986) (← links)
- HIV-Enhancing Factors Are Secreted by Reproductive Epithelia upon Inoculation with Bacterial Vaginosis-Associated Bacteria (Q35892272) (← links)
- HIV-1 vaginal transmission: cell-free or cell-associated virus? (Q35897398) (← links)
- Diffusion of Immunoglobulin G in Shed Vaginal Epithelial Cells and in Cell-Free Regions of Human Cervicovaginal Mucus (Q36064735) (← links)
- Predicting first traversal times for virions and nanoparticles in mucus with slowed diffusion (Q36066951) (← links)
- Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses (Q36118373) (← links)
- Enhanced Trapping of HIV-1 by Human Cervicovaginal Mucus Is Associated with Lactobacillus crispatus-Dominant Microbiota (Q36177529) (← links)
- New prospects for a preventive HIV-1 vaccine (Q36223864) (← links)
- Minimizing biases associated with tracking analysis of submicron particles in heterogeneous biological fluids (Q36396019) (← links)
- Using Computational Modeling To Optimize the Design of Antibodies That Trap Viruses in Mucus (Q36450159) (← links)
- The role of sex hormones in immune protection of the female reproductive tract (Q36473303) (← links)
- Broadly neutralizing antibody specificities detected in the genital tract of HIV-1 infected women (Q36753653) (← links)
- Engineering and characterization of simplified vaginal and seminal fluid simulants. (Q36890847) (← links)
- Mucosal immunology of HIV infection (Q36957775) (← links)
- Infectious virion capture by HIV-1 gp120-specific IgG from RV144 vaccinees (Q36978671) (← links)
- Vaginal concentrations of lactic acid potently inactivate HIV (Q37095477) (← links)
- Defining the interaction of HIV-1 with the mucosal barriers of the female reproductive tract (Q37252653) (← links)
- HIV-1-Neutralizing IgA Detected in Genital Secretions of Highly HIV-1-Exposed Seronegative Women on Oral Preexposure Prophylaxis (Q37347345) (← links)
- HIV-1 infection: the role of the gastrointestinal tract. (Q38201117) (← links)
- Secreted mucosal antimicrobials in the female reproductive tract that are important to consider for HIV prevention (Q38206217) (← links)
- Anatomic and hormonal changes in the female reproductive tract immune environment during the life cycle: implications for HIV/STI prevention research (Q38212118) (← links)
- Protein and oligonucleotide delivery systems for vaginal microbicides against viral STIs (Q38260862) (← links)
- Inflammation and HIV Transmission in Sub-Saharan Africa (Q38422546) (← links)
- Engineering immunity in the mucosal niche against sexually transmitted infections. (Q38543768) (← links)
- Complementary Assays Reveal a Low Level of CA Associated with Viral Complexes in the Nuclei of HIV-1-Infected Cells (Q38903364) (← links)
- Prolonged expression of an anti-HIV-1 gp120 minibody to the female rhesus macaque lower genital tract by AAV gene transfer (Q38981274) (← links)